4.7 Review

Principles for 3D/4D QSAR classification of drugs

Journal

DRUG DISCOVERY TODAY
Volume 13, Issue 21-22, Pages 952-959

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2008.07.006

Keywords

-

Funding

  1. Russian Foundation for Basic Researches [07-03-96041, 07-04-96053, 08-03-08015, 08-03-08016]
  2. SKIF - GRID Supercomputer Initiative, 'Human Capital Foundation' (London, Great Britain)

Ask authors/readers for more resources

The principles for the 3D/4D classification of drugs are introduced in this article. Based on these principles, new techniques for the reconstruction of complementary selfconsistent receptor fields for the classification of drugs, taking into account their multitautomeric and multiconformational states, are created. The series of examples of classification of drugs by their activity (active or nonactive), by their mechanisms of action, by their target and binding site and by the most important stages of their action are given. Prospects for rational drug design are highlighted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The study of EGFR-ligand complex electron property relationship with biological activity

Prateek Pathak, Vladislav Naumovich, Maria Grishina, Vladimir Potemkin

Summary: The present investigation estimated the electron properties of EGFR proteins-ligand complexes using AlteQ approach and established the relationship between electron properties and pharmacological activity. The study found that the inhibitory activity of EGFR is closely related to intermolecular contacts between protein and ligands.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemistry & Molecular Biology

Electronic properties investigation of human dihydrofolate reductase complexes with ligands

Vladislav Naumovich, Maria Grishina, Jurica Novak, Prateek Pathak, Vladimir Potemkin, Mohd Shahbaaz, Magda H. Abdellattif

Summary: This study investigates the interaction between human dihydrofolate reductase (hDHFR) and inhibitors, aiming to identify factors that can reduce side effects and enhance drug activity. Through calculation of electronic properties and statistical analysis, the researchers found that changes in volume and electron number correlated with hDHFR inhibition potency. Molecular dynamics simulations were also used to gain deeper insights into the structural inhibition. The AlteQ approach allowed for the quantitative evaluation of factors influencing activity.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemistry & Molecular Biology

In silico validation of novel inhibitors of malarial aspartyl protease, plasmepsin V and antimalarial efficacy prediction

Prem Prakash Sharma, Sumit Kumar, Kumar Kaushik, Archana Singh, Indrakant K. Singh, Maria Grishina, Kailash C. Pandey, Pushpendra Singh, Vladimir Potemkin, Poonam, Geeta Singh, Brijesh Rathi

Summary: Plasmepsin V is an essential protease for the survival of the malaria parasite Plasmodium falciparum, with inhibition showing potential as a drug target. Through molecular docking, a new compound has been identified as a potent inhibitor, which warrants further experimental validation.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemistry & Molecular Biology

Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking

Jurica Novak, Hrvoje Rimac, Shivananda Kandagalla, Prateek Pathak, Vladislav Naumovich, Maria Grishina, Vladimir Potemkin

Summary: The study identified a more favorable allosteric binding site on the SARS-CoV-2 3CL protease, which could be a better target for non-covalent inhibitors to prevent dimerization and activation. The tyrosine kinase inhibitors radotinib and nilotinib, used for leukemia treatment, showed potential binding to this allosteric site, as confirmed by molecular dynamics simulations.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemistry & Molecular Biology

Exploring potential inhibitors against Kyasanur forest disease by utilizing molecular dynamics simulations and ensemble docking

Shivananda Kandagalla, Jurica Novak, Sharath Belenahalli Shekarappa, Maria A. Grishina, Vladimir A. Potemkin, Bhimanagoud Kumbar

Summary: Kyasanur forest disease (KFD) is a tick-borne, neglected tropical disease caused by KFD virus (KFDV). This study evaluated the effectiveness of FDA approved drugs and natural compounds against KFDV proteins using in silico drug repurposing method.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemistry & Molecular Biology

Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study

Mohd Shahbaaz, Dmitry A. Maslov, Aleksey A. Vatlin, Valery N. Danilenko, Maria Grishina, Alan Christoffels

Summary: In the current era of a pandemic, infections of COVID-19 and Tuberculosis (TB) enhance the detrimental effects of both diseases in suffering individuals. The resistance mechanisms evolving in Mycobacterium tuberculosis are limiting the efficiency of current therapeutic measures and pressurizing the stressed medical infrastructures.

BIOMEDICINES (2022)

Article Chemistry, Medicinal

Establishment of models for reliability evaluation of 3CLpro ligand-receptor complexes with different binding sites

Vladislav Naumovich, Maria Grishina, Vladimir Potemkin

Summary: The aim of this study was to determine the significance of the 3CLpro enzyme of SARS-CoV-2 as a target for COVID-19 and evaluate the accuracy of drug modeling methods. The authors developed a model using the AlteQ approach to assess the reliability of 3CLpro complexes with ligands, which showed high correlation coefficients and can be utilized to determine the reliability of docked 3CLpro complexes with ligands.

FUTURE MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Debelalactone Prevents Hepatic Cancer via Diminishing the Inflammatory Response and Oxidative Stress on Male Wistar Rats

Prateek Pathak, Vikas Kumar, Habibullah Khalilullah, Maria Grishina, HariOm Singh, Amita Verma

Summary: The study demonstrates that debelalactone can protect tissues, alleviate chronic hepatic inflammation and oxidative stress induced by diethyl nitrosamine in Wistar rats. It significantly reduces parameters associated with liver and non-liver functions, and improves body weight of treated animals. Moreover, debelalactone restores antioxidant markers and inflammatory mediators to normal levels, reduces liver tissue abnormalities and inflammation, and inhibits precancerous cells.

MOLECULES (2022)

Review Chemistry, Medicinal

Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids

Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Harshali Paliwal, Suresh Thareja, Prateek Pathak, Maria Grishina, Mariusz Jaremko, Abdul-Hamid Emwas, Jagat Pal Yadav, Amita Verma, Habibullah Khalilullah, Pradeep Kumar

Summary: Cancer is a complex disease, and the efficacy of conventional anticancer drugs varies. The hybrid approach of combining two drugs into a single molecule shows potential in improving treatment efficacy and reducing drug resistance. Recent research has identified promising hybrid molecules with anticancer properties. This study provides valuable knowledge for researchers working on complex diseases like cancer.

PHARMACEUTICALS (2022)

Article Biochemistry & Molecular Biology

Guava Leaf Essential Oil as a Potent Antioxidant and Anticancer Agent: Validated through Experimental and Computational Study

Ashok Kumar Mandal, Samrat Paudel, Anisha Pandey, Parasmani Yadav, Prateek Pathak, Maria Grishina, Mariusz Jaremko, Abdul-Hamid Emwas, Habibullah Khalilullah, Amita Verma

Summary: The study investigated the antioxidant and anticancer activities of Psidium guajava L. essential oil, demonstrating its potential therapeutic value against breast cancer. The bioactive compounds in the oil showed promising properties in inhibiting tumor growth and exhibited drug likeness properties according to ADME analysis, suggesting their potential for novel drug discovery.

ANTIOXIDANTS (2022)

Review Chemistry, Medicinal

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective

Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas, Pradeep Kumar

Summary: Cancer is a major healthcare challenge worldwide, calling for the development of safer and target-specific anticancer drugs. This study summarizes the use of nitrogen-containing heterocycles in cancer treatment, providing insights into their pharmacological properties and mechanisms of action.

PHARMACEUTICALS (2023)

Review Pharmacology & Pharmacy

Illuminating the druggable genome: Pathways to progress

Karlie R. Sharma, Christine M. Colvis, Griffih P. Rodgers, Douglas M. Sheeley

Summary: There are many genes within the druggable genome that have not been studied, and the US National Institutes of Health's program provides resources to explore these genes, with the potential for rapid impact on human health.

DRUG DISCOVERY TODAY (2024)

Review Pharmacology & Pharmacy

Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment

Mohammad Sameer Khan, B. H. Jaswanth Gowda, Waleed H. Almalki, Tanuja Singh, Amirhossein Sahebkar, Prashant Kesharwani

Summary: Mitochondria-specific functional liposomes hold great potential for cancer therapy. This review discusses the association between mitochondria and tumor formation, as well as the advantages of liposomes in delivering drugs to mitochondria.

DRUG DISCOVERY TODAY (2024)

Review Pharmacology & Pharmacy

Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities

Choong Yong Ung, Cristina Correia, Hu Li, Christopher M. Adams, Jennifer J. Westendorf, Shizhen Zhu

Summary: With increasing human life expectancy, the global medical burden of chronic diseases is growing. Chronic diseases often involve malfunctioning of multiple organs, and understanding the interorgan crosstalk is crucial to understanding the etiology of chronic diseases. Researchers have proposed the locked-state model (LoSM) and cutting-edge systems biology and artificial intelligence strategies to decipher chronic multiorgan locked states. The findings have important clinical implications for improving treatments for chronic diseases.

DRUG DISCOVERY TODAY (2024)